Note: Ingredients listed on restricted chemical lists
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Revision date
2017-11-29
Product name
Polymyxin B for Injection, USP
Chemical name
N-[4-amino-1-[[1-[[4-amino-1-oxo-1-[[6,9,18-tris(2-aminoethyl)- 15-benzyl-3-(1-hydroxyethyl)-12-(2-methylpropyl)- 2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-
Emergency telephone
855-273-0154
Icons in SDS
Company Information
company name
Athenex Pharmaceutical Division
GHS Information
Signal word
Warning
Section 2
2.1 Classification of the substance or mixture
OSHA Classification: …
Signal word
c) Description of Hazards: Warning
Hazard statements
Symbol(s), and/or Precautionary
Potential Acute Health Effects
Hazardous in case of eye, skin contact (irritant), or inhalation Hazardous in case of eye, skin contact (irritant), or inhalation
Potential chronic health
Effects Hazardous in case of skin contact (irritant), or inhalation Gastrointestinal and/or respiratory tract irritation. Possible hyper sensitization and kidney damage. Effects Hazardous in case of skin contact (irritant), or inhalation Gastrointestinal and/or respiratory tract irritation. Possible hyper sensitization and kidney damage. Carcinogenic Effects: Not available Mutagenic Effects: E.coli DNA adduct test results: Positive. S. cerevisiae yeast mutagenicity test results: Positive.
Teratogenic Effects
Not available Developmental Toxicity: Not available Adverse effects: Adverse effects following ingestion may include dizziness, inability to coordinate muscular movements, visual disturbance, confusion, drowsiness, temporary absence of breathing, rash, fever, skin lesions and sensory disturbance of the face and extremities. Possible allergic reaction to material if inhaled, ingested or in contact with skin. (d) Unknown Acute Toxicity N/A
